METOCLOPRAMIDE
- Product NDC
- 36000-366
- 11-digit product format
- 360000366
- Labeler code
- 36000
- Product ID
- 36000-366_f6efdc63-a9df-4bbd-acf8-75fc9d1b0347
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- METOCLOPRAMIDE
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Baxter Healthcare Corporation
- Application
- ANDA217072
- Marketing category
- ANDA
- Marketing start
- 2026-09-11
- Substance
- METOCLOPRAMIDE HYDROCHLORIDE
- Active strength
- 5 mg/mL
- Pharmacologic classes
- Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Source provenance: Browse the complete Orange Book source catalog.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- METOCLOPRAMIDE
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| METOCLOPRAMIDE HYDROCHLORIDE | 5 mg/mL |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 36000-366-25 | 36000036625 | 25 VIAL, SINGLE-DOSE in 1 CARTON (36000-366-25) / 2 mL in 1 VIAL, SINGLE-DOSE (36000-366-01) | 2026-09-11 | No | No | Current |